Wuhan YZY Biopharma Co., Ltd. (HKG:2496)
7.24
-0.52 (-6.70%)
Feb 10, 2026, 2:14 PM HKT
Wuhan YZY Biopharma Revenue
Wuhan YZY Biopharma had revenue of 44.37M CNY in the half year ending June 30, 2025, with 558.59% growth. This brings the company's revenue in the last twelve months to 149.35M. In the year 2024, Wuhan YZY Biopharma had annual revenue of 107.81M.
Revenue (ttm)
149.35M CNY
Revenue Growth
n/a
P/S Ratio
8.58
Revenue / Employee
1.41M CNY
Employees
106
Market Cap
1.40B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 107.81M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 2.28M | -9.89M | -81.28% |
| Dec 31, 2021 | 12.16M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition